Cargando…
P64. T cell re-direction against Glypican-3 for immunotherapy of hepatocellular carcinoma
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072158/ http://dx.doi.org/10.1186/2051-1426-2-S2-P38 |
_version_ | 1782322914936225792 |
---|---|
author | Dargel, C Bassani-Sternberg, M Krebs, K Wilde, S Schendel, D Busch, DH Mann, M Protzer, U |
author_facet | Dargel, C Bassani-Sternberg, M Krebs, K Wilde, S Schendel, D Busch, DH Mann, M Protzer, U |
author_sort | Dargel, C |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4072158 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-40721582014-06-27 P64. T cell re-direction against Glypican-3 for immunotherapy of hepatocellular carcinoma Dargel, C Bassani-Sternberg, M Krebs, K Wilde, S Schendel, D Busch, DH Mann, M Protzer, U J Immunother Cancer Poster Presentation BioMed Central 2014-03-12 /pmc/articles/PMC4072158/ http://dx.doi.org/10.1186/2051-1426-2-S2-P38 Text en Copyright © 2014 Dargel et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Poster Presentation Dargel, C Bassani-Sternberg, M Krebs, K Wilde, S Schendel, D Busch, DH Mann, M Protzer, U P64. T cell re-direction against Glypican-3 for immunotherapy of hepatocellular carcinoma |
title | P64. T cell re-direction against Glypican-3 for immunotherapy of hepatocellular carcinoma |
title_full | P64. T cell re-direction against Glypican-3 for immunotherapy of hepatocellular carcinoma |
title_fullStr | P64. T cell re-direction against Glypican-3 for immunotherapy of hepatocellular carcinoma |
title_full_unstemmed | P64. T cell re-direction against Glypican-3 for immunotherapy of hepatocellular carcinoma |
title_short | P64. T cell re-direction against Glypican-3 for immunotherapy of hepatocellular carcinoma |
title_sort | p64. t cell re-direction against glypican-3 for immunotherapy of hepatocellular carcinoma |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072158/ http://dx.doi.org/10.1186/2051-1426-2-S2-P38 |
work_keys_str_mv | AT dargelc p64tcellredirectionagainstglypican3forimmunotherapyofhepatocellularcarcinoma AT bassanisternbergm p64tcellredirectionagainstglypican3forimmunotherapyofhepatocellularcarcinoma AT krebsk p64tcellredirectionagainstglypican3forimmunotherapyofhepatocellularcarcinoma AT wildes p64tcellredirectionagainstglypican3forimmunotherapyofhepatocellularcarcinoma AT schendeld p64tcellredirectionagainstglypican3forimmunotherapyofhepatocellularcarcinoma AT buschdh p64tcellredirectionagainstglypican3forimmunotherapyofhepatocellularcarcinoma AT mannm p64tcellredirectionagainstglypican3forimmunotherapyofhepatocellularcarcinoma AT protzeru p64tcellredirectionagainstglypican3forimmunotherapyofhepatocellularcarcinoma |